GLP-1 telehealth programs use subscription models to structure access, billing, and clinician oversight
However, the treatment landscape has seen significant changes in the past five years, with several late-phase candidates in development
How PlexusDx Supports a More Personalized Approach PlexusDx's approach to compounded medication management integrates biomarker and genetic context with practical safety protocols
Chemical Peels for Melasma and skin lightening For patients with darker skin types Dr
In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
In the brain, mast cell-derived mediators interact with microglia , the central nervous systems resident immune cells